NCR Online Journal

The Complex Regional Pain Syndrome Epidemiology report covers the descriptive overview of Hemophilia A, explaining its facts, and symptoms

 Breaking News
  • No posts were found

The Complex Regional Pain Syndrome Epidemiology report covers the descriptive overview of Hemophilia A, explaining its facts, and symptoms

March 19
22:59 2021
The Complex Regional Pain Syndrome Epidemiology report covers the descriptive overview of Hemophilia A, explaining its facts, and symptoms

 

Complex Regional Pain Syndrome Epidemiology” report has been recently added to DelveInsight

 

About Complex Regional Pain Syndrome

Complex regional pain syndrome (CRPS) is defined as a “painful syndrome, which includes regional pain, sensory changes (e.g. allodynia), abnormalities of temperature, abnormal sudomotor activity, edema and an abnormal skin color that occurs after an initiating noxious event such as trauma etc.” CRPS may develop after major trauma, surgery, or minor injury, and progresses with a variable course that ranges from self-limiting, mild symptomatology to chronic disease.

 

Request for free sample copy of CRPS epidemiology report- https://www.delveinsight.com/sample-request/complex-regional-pain-syndrome-epidemiology-forecast

 

Complex Regional Pain Syndrome Epidemiology

“CRPS-I is a syndrome characterized by a continuing (spontaneous and/or evoked) regional pain that is seemingly disproportionate in time or degree to the usual course of pain after trauma or another lesion. The pain is regional (not in a specific nerve territory or dermatome) and usually has a distal predominance of abnormal sensory, motor, sudomotor, vasomotor/edema and/or trophic findings. The syndrome shows variable progression over time. CRPS-I occurs after any form of trauma, particularly a fracture or soft tissue lesion. CRPS-II occurs after nerve damage.”

 

Important key facts of Complex Regional Pain Syndrome epidemiology report

  • According to DelveInsight estimates, total cases of Complex Regional Pain Syndrome (CRPS) in the 7MM were found to be 253,603 in 2017. Among all the countries, the United States have higher population CRPS in 2017
  • Among the EU5 countries, Germany had the population of CRPS with 18,459 cases, followed by UK and the France. On the other hand, Spain had the lowest population. As per our estimates, Japan had 5,333 cases of CRPS in 2017
  • Based on the type, CRPS has been categorized into CRPS Type I, CRPS Type II and CRPS NOS (Not otherwise specified). As per DelveInsight insights, CRPS I accounts for the maximum number of cases for the study period compared to other types
  • As per DelveInsight’s analysts, the overall cases of CRPS in both the genders is subjected to increase in the coming years, although females are more frequently affected by CRPS than males.
  • The most common events associated for trigger of CRPS are fractures, followed by surgery, soft tissue injury, nerve injury, electric injury and others

 

Complex Regional Pain Syndrome epidemiology segmentation

  • Total Cases of CRPS in 7MM [2017 –2030]
  • Gender-specific cases of CRPS [2017 –2030]
  • Diagnosed cases of CRPS [2017 –2030]
  • Type-specific diagnosed cases of CRPS [2017 –2030]
  • Number of CRPS in associated triggered factors [2017 –2030]

 

Complex Regional Pain Syndrome Treatment

Currently, the treatment of CRPS is restricted to palliative care and symptom-based interventions such as Non-opioid analgesics (Paracetamol, NSAIDs, Nefopam etc.), Weak opioid analgesics (Tramadol, Codeine/Acetaminophen, Opium/PCM etc.), Strong opioid analgesics, Co-analgesics (Corticosteroids, Antiepileptics, Antidepressants, Tricyclic Antidepressants, SNRIs, Bisphosphonate, IV Bisphosphonate, Calcitonin, Ketamine etc.), Local treatment (Joint infusion of corticosteroids, Lidocaine cream, Lidocaine patch, Capsaicin, NSAIDs etc.) and others (including Physiotherapy, surgery, Psychological interventions etc.). Currently, Neridronate is the only first line drug that has showed its efficacy in CRPS patients and available in the Italy market. It is the only therapy approved for the treatment of CRPS in Italy (Abiogen Pharma).

 

Complex Regional Pain Syndrome Epidemiology: Report Highlights

  • 11-Year Forecast of CRPS epidemiology
  • 7MM Coverage
  • Total prevalent Cases of CRPS
  • Total diagnosed prevalent cases of CRPS
  • Gender-specific diagnosed prevalent cases of CRPS
  • Age-specific diagnosed prevalent cases of CRPS
  • Type-specific diagnosed prevalent cases of CRPS
  • Severity-specific diagnosed prevalent cases of CRPS
  • Treated cases of CRPS

 

Request for free sample copy of CRPS epidemiology report- https://www.delveinsight.com/sample-request/complex-regional-pain-syndrome-epidemiology-forecast

 

Following is the table of content of Complex Regional Pain Syndrome Epidemiology Report

1. Key Insights

2. Executive Summary of Complex Regional Pain Syndrome (CRPS)

3. Complex Regional Pain Syndrome (CRPS): Disease Background and Overview

5. Appendix

6. DelveInsight Capabilities

7. Disclaimer

8. About DelveInsight

 

What are the important reasons to buy?

  • Develop business strategies by understanding the trends shaping and driving the global CRPS market
  • Quantify patient populations in the global CRPS market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and gender that present the best opportunities for CRPS therapeutics in each of the markets covered
  • Understand the magnitude of CRPS population by its severity
  • The CRPS epidemiology report and model were written and developed by Masters and PhD level epidemiologists
  • The CRPS Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 

Related Report

 

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles